“The healthcare industry is responsible for 5% of global emissions, which is more than aviation,” says Robert Williams Director of Sustainable Procurement at AstraZeneca. As Vice Chair of the Pharmaceutical Supply Chain Initiative (PSCI), he regularly engages with a wide
AstraZeneca has announced plans to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs). This greenfield facility, supported by the Singapore Economic Development Board (EDB), will be the company’s first end-to-end ADC production site, fully incorporating
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
